Michael Baptista, MD Logo
Medical Weight Loss

GLP-1 Medications or Bariatric Surgery? How to Think About the Choice

Dr. Michael Baptista, a Jacksonville bariatric surgeon who offers both, walks through how GLP-1 medications and bariatric surgery compare on results, durability, eligibility, and daily life, and why the answer is personal.

Dr. Michael Baptista, MD
Bariatric and General Surgeon · October 21, 2026 · 7 min read
Dr. Michael Baptista, bariatric surgeon in Jacksonville, Florida, with a patient

The Short Answer

GLP-1 medications and bariatric surgery are both effective treatments for obesity. They differ in how much weight they typically help patients lose, how durable the results are, who qualifies, and what daily life looks like during treatment. The right choice depends on your health, how much weight you should lose, your history, and what you are prepared to commit to. This article lays out the differences so your first conversation with a bariatric surgeon can start further along.

Two Tools, Not Two Teams

It helps to know where I am coming from. I’m a fellowship-trained bariatric surgeon. I have performed thousands of weight loss surgeries. I have a robust pre- and post-surgical program where we guide patients for years and decades in how to keep their weight loss. I also run a physician-supervised medical weight loss program that includes GLP-1 medications. Patients in my program are evaluated for every option, and my goal is to aid patients in choosing the right treatment for them. My vast experience and knowledge in the follow-up gives patients a great advantage in succeeding with their weight loss.

What Each Option Typically Achieves

Bariatric surgery. Procedures such as the gastric sleeve and gastric bypass typically produce total body weight loss in the range of 25 to 40 percent, with much of that occurring in the first year. Improvements in type 2 diabetes, high blood pressure, and sleep apnea are common and often substantial. Surgery remains the most effective treatment available for severe obesity.

GLP-1 medications. In clinical trials, GLP-1 medications approved for weight management have produced average total body weight loss in the mid-teens to around 20 percent over one to two years, depending on the medication and the patient. Improvements in blood sugar and cardiovascular risk markers have also been reported. These are meaningful results, well beyond what diet and exercise alone typically achieve, which is below 10 percent.

Which medications are currently approved for weight management, and how they differ, is covered on our weight loss medications page. I do not recommend one medication over another in general terms. That decision is made with each patient during evaluation.

How Long the Results Last

This is where the two options differ most, and it is the part patients least often hear about.

Bariatric surgery changes the anatomy of the digestive system, and the effect persists. Most patients maintain the majority of their weight loss for many years. Over time, a small number of patients can experience a slow weight regain, which is why long-term follow-up matters and why medication is now being studied as a tool for those patients. I wrote about that separately: GLP-1 medications after bariatric surgery.

GLP-1 medications work while you take them. In the STEP 1 trial extension, participants who stopped semaglutide regained about two-thirds of the weight they had lost within a year of stopping. Real-world data suggest that roughly half of patients who start a GLP-1 medication discontinue within the first year, for reasons that include side effects, cost, and access. Researchers increasingly describe obesity as a chronic condition that requires ongoing treatment, the way high blood pressure does. For medication, that means planning for the long term, not a short course.

Neither of these facts makes one option better. They describe different commitments. Surgery is a one-time procedure with lifelong effects and lifelong follow-up. Medication is an ongoing treatment that can be adjusted or stopped, with the understanding that stopping usually means the weight returns.

Who Qualifies

Eligibility overlaps, but it is not identical.

Under guidelines from the American Society for Metabolic and Bariatric Surgery and the International Federation for the Surgery of Obesity, bariatric surgery is generally recommended for adults with a body mass index of 35 or higher regardless of other conditions, and considered for adults with a BMI of 30 or higher who have metabolic disease such as type 2 diabetes.

GLP-1 medications approved for weight management are generally indicated for adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol.

If your BMI is between 30 and 35, you may qualify for both, and the decision becomes personal. If your BMI is well above 40, or you have diabetes that has been hard to control, surgery may offer a degree of improvement that medication alone is less likely to match. If you are in the overweight range with a related health condition, medication may be the only one of the two that applies. Every one of those statements has exceptions, which is the point of an evaluation.

Questions Worth Asking Yourself

Before your consultation, it is worth thinking honestly about a few things:

  • How much weight are you hoping to lose, and what has your experience been with previous attempts?
  • Do you have diabetes, sleep apnea, high blood pressure, or another condition that weight loss would directly improve?
  • Are you comfortable with a surgical procedure and the recovery it involves, or would you rather start with something that does not involve an operation?
  • Are you prepared for an ongoing prescription, including regular follow-up visits and the possibility of side effects, for as long as you want to maintain the result?
  • What does your insurance cover, and what can you sustain financially over years rather than months?

There are no wrong answers. They simply point toward different paths.

Sometimes the Answer Is Both

Increasingly, these are not competing options but tools used at different points. Some patients use medication before surgery to reduce surgical risk. Some patients who had surgery years ago use medication to address regain. Some patients start with medication, learn that it is not enough on its own, and move to surgery with a clearer picture of what they need. A physician who offers both can help you sequence them rather than choosing one and hoping.

What a Physician-Supervised Program Looks Like

Our Medical Weight Loss Program is a six-month, physician-supervised program that begins with an evaluation with me. Medication is prescribed when appropriate. Patients have monthly follow-up visits, work with a dietitian, and have a dedicated patient care specialist between visits. Surgical options are part of the same conversation when they make sense. The program serves current patients, or new patients.

A Note on Insurance

Our team will assist you in verifying your benefits, however insurance coverage can vary based on your specific plan and it is always subject to change. We encourage patients to contact their insurance provider directly to confirm coverage and benefits.

The Next Step

If you have been weighing these options, the most useful next step is an evaluation with a bariatric surgeon who offers both. Call our office at (904) 724-2263 or contact us online. You can also read about our Medical Weight Loss Program, explore weight loss surgery options, or review our medical weight loss FAQ.

Sources

  • Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes, Obesity and Metabolism. 2022;24(8):1553-1564.
  • Trajectory of weight regain after cessation of GLP-1 receptor agonists: a systematic review and nonlinear meta-regression. eClinicalMedicine. 2026.
  • Lauer KV, Harris DA, Funk LM. The GLP-1 Era: What Comes After Bariatric Surgery? JAMA Surgery. 2025;160(10):1066-1067.
  • Eisenberg D, et al. 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery. Surgery for Obesity and Related Diseases. 2022.

This article is for general education and is not a substitute for medical advice. Please see our medical disclaimer.

We use cookies to understand site usage and improve your experience. No tracking runs on medical procedure pages. See our Privacy Policy for details.